End-stage kidney disease (ESKD) is a common and morbid disease that affects patients'
quality and length of life, representing a large portion of health care expenditure in the …

Background The goal of HD access is to provide simple and reproducible access to the
patient's circulatory system, while minimizing complications. There are three main options to …

Purpose To investigate the use of a sirolimus drug-coated balloon (DCB) in the
management of a thrombosed arteriovenous graft (AVG). Materials and Methods A single …

Introduction Patients with end-stage renal disease may require arteriovenous (AV) access in
the form of arteriovenous fistulae (AVFs) or arteriovenous grafts (AVGs) for haemodialysis …

Over the past two decades, hemodialysis access interventions joined the era of evidence-
based medicine. Before then, catheter-directed access interventions were largely based …

Background Percutaneous transluminal angioplasty is the current standard treatment for
arteriovenous fistula (AVF) stenosis. The mid-and long-term patency with plain balloon …

A one‐size‐fits‐all approach to vascular access for dialysis may be prejudicial.
Arteriovenous fistulae (AVF) have high primary failure, failure to mature rate, and late‐stage …

Background: Early-cannulation arteriovenous grafts (ecAVG) have good initial patency, but
frequent episodes of reintervention for venous stenosis (VS) and thrombosis limit their use …

Objective Arteriovenous graft (AVG) failures are typically associated with venous
anastomotic (VA) stenosis. Current evidence regarding AVG thrombosis management …

Background Central venous occlusive disease is a common cause of upper extremity
arteriovenous access dysfunction in hemodialysis patients. When refractory to balloon …